548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progression

Aram Lyu(Fred Hutch Cancer Center), Lawrence Fong(UCSF Helen Diller Family Comprehensive Cancer Center), Diamond Luong(University of California, San Francisco), Zenghua Fan(University of California, San Francisco), Ali Setayesh(University of California, San Francisco), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Alec Starzinski(University of California, San Francisco)
Regular and Young Investigator Award Abstracts
October 31, 2023
10.1136/jitc-2023-sitc2023.0548
Cited by 1

Related Papers

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k